EDCs can cause serious and irreversible effects on human health and the environment, even at very low doses. Proper identification and risk management are crucial for regulatory compliance and safety.
| Criteria | Description | Examples |
|---|---|---|
| WHO/IPCS Definition | Alters function of endocrine system causing adverse effects | BPA, Phthalates, PCBs |
| EU Criteria | Shows endocrine mode of action with adverse effects | DEHP, DBP, BBP |
| Suspected EDCs | Some evidence of endocrine disruption | Various pesticides, plasticizers |
| Level | Test Methods | Endpoints |
|---|---|---|
| In vitro | Receptor binding, Cell proliferation | Mechanistic information |
| In vivo screening | Uterotrophic, Hershberger assays | Endocrine activity |
| Definitive tests | Extended one-generation studies | Adverse effects |